Lifespan predicting DNA test to go on sale

By Admin
Share
A revolutionary DNA blood test that can predict how long you will live is due to go on sale in Europe and possibly in America. The blood test will be a...

A revolutionary DNA blood test that can predict how long you will live is due to go on sale in Europe and possibly in America.

The blood test will be available in over-the-counter settings and will cost $700 (£435) when it first goes on sale in Britain later this year.

The test identifies the length of a person’s telomeres which are bits of DNA at the end of the chromosomes.

READ MORE FROM THE WDM CONTENT NETWORK:
To read the latest edition of Healthcare Global,
click here
Many people in the US use the internet for medical advice
Twitter is a vital link to patients
iPad 'spinal surgery recovery tracker' is being trialled

Scientists believe that telomeres indicate the speed at which someone ages and those with shorter telomeres tend to die younger than those with long telomeres.

However, critics are branding it controversial and are saying it will open a ‘Pandora’s box’ in which insurance companies will demand a blood test before offering a policy.

Some scientists are also concerned about how people will react if the test delivers bad news, while others are worried it could be used to market fake ‘elixirs of life’.   

A Madrid-based company Life Length has manufactured the test and in an interview Life Length CEO Steve Matlin said the company does not claim the test can predict length of life, it merely just alerts people to high concentrations of short telomeres.

As yet the test is unable to predict the exact amount of months or years a person has left to live although scientists believe telomere testing will become widespread within the next ten years.

Life Length itself is also predicting the demand for the test will be high once they can bring down the price of the test.

Although Life Length is not the only company offering telomere blood tests, they are the only company to be making them available to the public over-the-counter.  

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma